Trial Profile
Phase 4 study of once-daily intramuscular cefepime versus ceftriaxone for in-home treatment of nursing home-acquired pneumonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2007
Price :
$35
*
At a glance
- Drugs Cefepime (Primary) ; Ceftriaxone
- Indications Bacterial infections; Nosocomial pneumonia; Pneumonia
- Focus Therapeutic Use
- 02 Nov 2007 End date updated from nct (dms 1/11/07).
- 03 Nov 2006 New trial record.